Juvenile rheumatoid arthritis

Insights

Juvenile rheumatoid arthritis (JRA) is a common childhood connective tissue disease causing chronic arthritis, potentially leading to disability and blindness. JRA presents and progresses differently than adult rheumatoid arthritis, with distinct subtypes impacting treatment and outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Connective Tissue Diseases

Background:

  • Juvenile rheumatoid arthritis (JRA) is the most prevalent connective tissue disease in children.
  • JRA can lead to significant long-term health issues, including disability and vision impairment.
  • Understanding JRA is crucial for effective pediatric healthcare.

Purpose of the Study:

  • To differentiate juvenile rheumatoid arthritis from its adult counterpart.
  • To outline the distinct clinical presentations, laboratory findings, and prognoses of JRA.
  • To detail the current classification of JRA into systemic, pauciarticular, and polyarticular types.

Main Methods:

  • Review of existing literature on juvenile rheumatoid arthritis.
  • Analysis of clinical and laboratory data differentiating pediatric and adult rheumatoid arthritis.
  • Examination of classification systems for juvenile rheumatoid arthritis.

Main Results:

  • Juvenile rheumatoid arthritis exhibits unique characteristics compared to adult rheumatoid arthritis in terms of presentation, diagnostics, and prognosis.
  • The classification of JRA into systemic, pauciarticular, and polyarticular forms is essential.
  • Each JRA subtype carries specific therapeutic strategies and prognostic expectations.

Conclusions:

  • Juvenile rheumatoid arthritis requires specialized diagnostic and therapeutic approaches distinct from adult rheumatoid arthritis.
  • Accurate classification of JRA subtypes is critical for optimizing patient management and outcomes.
  • Further research into JRA pathogenesis and treatment is warranted.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...